Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,3S,4S,5R,6S)-6-(4-((3R,4S,7S,10S)-4-sec-butyl-15-(1-(39-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-34-oxo-3,6,9,12,15,18,21,24,27,30-decaoxa-33-azanonatriacontyl)-1H-1,2,3-triazol-4-yl)-3-(2-((S)-2-((1R,2R)-3-((1S,2R)-1-hydroxy-1-phenylpropan-2-ylamino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-2-oxoethyl)-7,10-diisopropyl-5,11-dimethyl-6,9,12-trioxo-2,13-dioxa-5,8,11-triazapentadecan-14-yl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
ID: ALA4591313
PubChem CID: 155568348
Max Phase: Preclinical
Molecular Formula: C88H139N11O31
Molecular Weight: 1847.13
Molecule Type: Unknown
Associated Items: